3-Epi-25-hydroxyvitamin D3 is a poor substrate for SULT2A1: Analysis of its 3-sulfate in cord plasma and recombinant human SULT2A1 incubate - ScienceDirect
Vitamin D3 25-Hydroxyvitamin D: Reference Range, Interpretation, Collection and Panels
25-OH Vitamin D ELISA | Calbiotech
Vitamin D (25OH) (Free) ELISA, KARF1991 (RUO) | Human Vitamin D Free Enzyme-linked Immune-sorbent Assay Kit IBL-America
IJMS | Free Full-Text | A Narrative Role of Vitamin D and Its Receptor: With Current Evidence on the Gastric Tissues
Vitamin D deficiency - Wikipedia
Vitamin D Supplement Reviews & Top Picks - ConsumerLab.com
IJMS | Free Full-Text | Epimers of Vitamin D: A Review
25-OH-Vitamin D3/D2 in Serum/Plasma - HPLC
COVID-19 mortality risk correlates inversely with vitamin D3 status, and a mortality rate close to zero could theoretically be achieved at 50 ng/ml 25( OH)D3: Results of a systematic review and meta-analysis
Vitamin D3 metabolite ratio as an indicator of vitamin D status and its association with diabetes complications | BMC Endocrine Disorders | Full Text
25-OH Vitamin D3 (Highly Pure) - Molecular Depot
Vitamin D, beyond the bone
Sulfation of vitamin D3‐related compounds—identification and characterization of the responsible human cytosolic sulfotransferases - Kurogi - 2017 - FEBS Letters - Wiley Online Library
Ratio of 25(OH)D-to-24,25(OH)2D: A new test to confirm 24-hydroxylase (CYP24A1) deficiency as the cause of hypercalcemia - Mayo Clinic
Frontiers | Focus on 1,25-Dihydroxyvitamin D3 in the Peripheral Nervous System
Vitamin D deficiency test -- Everything you wanted to know about this blood test | TheHealthSite.com
Metabolism of 25-hydroxyvitamin D [25(OH)D] to 1,25 dihydroxyvitamin D... | Download Scientific Diagram
Vitamin D3 25-Hydroxyvitamin D: Reference Range, Interpretation, Collection and Panels
In vitro metabolic activation of vitamin D3 by using a multi-compartment microfluidic liver-kidney organ on chip platform | Scientific Reports
Vitamin D: 13 ng/mL
Frontiers | Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond